Immune diseases associated with TREX1 and STING dysfunction

Journal of Interferon and Cytokine Research

Volumn 37, Issue 5, 2017, Pages 198-206

  Yan, Nan ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Aicardi Gouti res syndrome; Cytosolic DNA sensing; Retinal vasculopathy with cerebral leukodystrophy; STING; STING associated vasculopathy with onset in infancy; TREX1

Indexed keywords

ADAPTOR PROTEIN; ANTINEOPLASTIC AGENT; CELL DNA; DEOXYRIBONUCLEASE; REGULATOR PROTEIN; STING PROTEIN; TREX1 PROTEIN; UNCLASSIFIED DRUG; EXODEOXYRIBONUCLEASE; MEMBRANE PROTEIN; MPYS PROTEIN, HUMAN; PHOSPHOPROTEIN; THREE PRIME REPAIR EXONUCLEASE 1;

AICARDI GOUTIERES SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; CANCER IMMUNOTHERAPY; CLINICAL TRIAL (TOPIC); CYTOSOL; ENZYME STRUCTURE; GAIN OF FUNCTION MUTATION; HUMAN; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; INFLAMMATORY DISEASE; INNATE IMMUNITY; LEUKODYSTROPHY; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RETROVIRUS INFECTION; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULAR DISEASE; VIRUS IMMUNITY; METABOLISM; PATHOPHYSIOLOGY;

EXODEOXYRIBONUCLEASES; HUMANS; IMMUNE SYSTEM DISEASES; MEMBRANE PROTEINS; PHOSPHOPROTEINS;

EID: 85019099719     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2016.0086     Document Type: Article

References (72)

1. Ahn J, Gutman D, Saijo S, Barber GN. 2012. STING manifests self DNA-dependent inflammatory disease. Proc Natl Acad Sci U S A 109: 19386-19391.
2. Ahn J, Ruiz P, Barber GN. 2014. Intrinsic self-DNA triggers inflammatory disease dependent on STING. J Immunol 193: 4634-4642.
3. Barber GN. 2011. STING-dependent signaling. Nat Immunol 12: 929-930.
4. Barber GN. 2014. STING-dependent cytosolic DNA sensing pathways. Trends Immunol 35: 88-93.
5. Bennett DC, Charest J, Sebolt K, Lehrman M, Rehemtulla A, Contessa JN. 2013. High-throughput screening identifies aclacinomycin as a radiosensitizer of EGFR-mutant nonsmall cell lung cancer. Transl Oncol 6: 382-391.
6. Brucet M, Querol-Audí J, Bertlik K, Lloberas J, Fita I, Celada A. 2008. Structural and biochemical studies of TREX1 inhibition by metals. Identification of a new active histidine conserved in DEDDh exonucleases. Protein Sci 17: 2059-2069.
7. Burnaevskiy N, Fox TG, Plymire DA, Ertelt JM, Weigele BA, Selyunin AS, Way SS, Patrie SM, Alto NM. 2013. Proteolytic elimination of N-myristoyl modifications by the Shigella virulence factor IpaJ. Nature 496: 106-109.
8. Chui D, Sellakumar G, Green R, Sutton-Smith M, McQuistan T, Marek K, Morris H, Dell A, Marth J. 2001. Genetic remodeling of protein glycosylation in vivo induces autoimmune disease. Proc Natl Acad Sci U S A 98: 1142-1147.
9. Collins AC, Cai H, Li T, Franco LH, Li, X-D, Nair VR, Scharn CR, Stamm CE, Levine B, Chen ZJ, et al. 2015. Cyclic GMP-AMP synthase is an innate immune DNA sensor for Mycobacterium tuberculosis. Cell Host Microbe 17: 820-828.
10. Corrales L, Glickman LH, McWhirter SM, Kanne DB, Sivick KE, Katibah GE, Woo, S-R, Lemmens E, Banda T, Leong JJ, et al. 2015. Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity. Cell Rep 11: 1018-1030.
11. Corrales L, McWhirter SM, Dubensky TW, Gajewski TF. 2016. The host STING pathway at the interface of cancer and immunity. J Clin Invest 126: 2404-2411.
12. Crow MK, Olferiev M, Kirou KA. 2015. Targeting of type I interferon in systemic autoimmune diseases. Transl Res 165: 296-305.
13. Crow YJ, Hayward B, Parmar R, Robins P, Leitch A, Ali M, Black D, van Bokhoven H, Brunner H, Hamel B, et al. 2006. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutieres syndrome at the AGS1 locus. Nat Genet 38: 917-920.
14. Crow YJ, Rehwinkel J. 2009. Aicardi-Goutieres syndrome and related phenotypes: Linking nucleic acid metabolism with autoimmunity. Hum Mol Genet 18: R130-R136.
15. de Silva U, Choudhury S, Bailey SL, Harvey S, Perrino FW, Hollis T. 2007. The crystal structure of TREX1 explains the 3' nucleotide specificity and reveals a polyproline II helix for protein partnering. J Biol Chem 282: 10537-10543.
16. Dobbs N, Burnaevskiy N, Chen D, Gonugunta VK, Alto NM, Yan N. 2015. STING activation by translocation from the ER is associated with infection and autoinflammatory disease. Cell Host Microbe 18: 157-168.
17. Frémond, M-L, Rodero MP, Jeremiah N, Belot A, Jeziorski E, Duffy D, Bessis D, Cros G, Rice GI, Charbit B, et al. 2016. Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in three children. J Allergy Clin Immunol 138: 1752-1755.
18. Fu J, Kanne DB, Leong M, Glickman LH, McWhirter SM, Lemmens E, Mechette K, Leong JJ, Lauer P, Liu W, et al. 2015. STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade. Sci Transl Med 7: 283ra52.
19. Fye JM, Orebaugh CD, Coffin SR, Hollis T, Perrino FW. 2011. TREX1 dominant mutations in lupus and Aicardi-Goutieres syndrome. J Biol Chem 286: 32373-32382.
20. Gall A, Treuting P, Elkon KB, Loo, Y-M, Gale M, Barber GN, Stetson DB. 2012. Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent Autoimmune Disease. Immunity 36: 120-131.
21. Gao D, Li T, Li, X-D, Chen X, Li, Q-Z, Wight-Carter M, Chen ZJ. 2015. Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune diseases. Proc Natl Acad Sci U S A 112: E5699-E5705.
22. Gao D, Wu J, Wu, Y-T, Du F, Aroh C, Yan N, Sun L, Chen ZJ. 2013. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 341: 903-906.
23. Gray EE, Treuting PM, Woodward JJ, Stetson DB. 2015. Cutting edge: CGAS is required for lethal autoimmune disease in the Trex1-deficient mouse model of Aicardi-Goutières syndrome. J Immunol 195: 1939-1943.
24. Green RS, Stone EL, Tenno M, Lehtonen E, Farquhar MG, Marth JD. 2007. Mammalian N-glycan branching protects against innate immune self-recognition and inflammation in autoimmune disease pathogenesis. Immunity 27: 308-320.
25. Grieves JL, Fye JM, Harvey S, Grayson JM, Hollis T, Perrino FW. 2015. Exonuclease TREX1 degrades double-stranded DNA to prevent spontaneous lupus-like inflammatory disease. Proc Natl Acad Sci U S A 112: 5117-5122.
26. Hasan M, Dobbs N, Khan S, White MA, Wakeland EK, Li, Q-Z, Yan N. 2015a. Cutting edge: Inhibiting TBK1 by Compound II Ameliorates Autoimmune Disease in mice. J Immunol 195: 4573-4577.
27. Hasan M, Fermaintt CS, Gao N, Sakai T, Miyazaki T, Jiang S, Li, Q-Z, Atkinson JP, Morse HC, III, Lehrman MA, et al. 2015b. Cytosolic nuclease TREX1 regulates oligosaccharyltransferase activity independent of nuclease activity to suppress immune activation. Immunity 43: 1-13.
28. Hasan M, Koch J, Rakheja D, Pattnaik AK, Brugarolas J, Dozmorov I, Levine B, Wakeland EK, Lee-Kirsch MA, Yan N. 2013. Trex1 regulates lysosomal biogenesis and interferonindependent activation of antiviral genes. Nat Immunol 14: 61-71.
29. Hasan M, Yan N. 2014. Safeguard against DNA sensing: The role of TREX1 in HIV-1 infection and autoimmune diseases. Front Microbiol 5: 193.
30. Hasan M, Yan N. 2016. Therapeutic potential of targeting TBK1 in autoimmune diseases and interferonopathies. Pharmacol Res 111: 336-342.
31. Herzner, A-M, Hagmann CA, Goldeck M, Wolter S, Kübler K, Wittmann S, Gramberg T, Andreeva L, Hopfner, K-P, Mertens C, et al. 2015. Sequence-specific activation of the DNA sensor cGAS by Y-form DNA structures as found in primary HIV-1 cDNA. Nat Immunol 16: 1025-1033.
32. Ishii KJ, Coban C, Kato H, Takahashi K, Torii Y, Takeshita F, Ludwig H, Sutter G, Suzuki K, Hemmi H, et al. 2006. A Tolllike receptor-independent antiviral response induced by double-stranded B-form DNA. Nat Immunol 7: 40-48.
33. Ishikawa H, Ma Z, Barber GN. 2009. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461: 788-792.
34. Jeremiah N, Neven B, Gentili M, Callebaut I, Maschalidi S, Stolzenberg, M-C, Goudin N, Frémond, M-L, Nitschke P, Molina TJ, et al. 2014. Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations. J Clin Invest 124: 5516-5520.
35. Kawane K, Ohtani M, Miwa K, Kizawa T, Kanbara Y, Yoshioka Y, Yoshikawa H, Nagata S. 2006. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 443: 998-1002.
36. Kelleher DJ, Gilmore R. 2006. An evolving view of the eukaryotic oligosaccharyltransferase. Glycobiology 16: 47R-62R.
37. König N, Fiehn C, Wolf C, Schuster M, Costa EC, Tüngler V, Alvarez HA, Chara O, Engel K, Goldbach-Mansky R, et al. 2017. Familial chilblain lupus due to a gain-of-function mutation in STING. Ann Rheum Dis 76: 468-472.
38. Konno H, Konno K, Barber GN. 2013. Cyclic dinucleotides trigger ULK1 (ATG1) phosphorylation of STING to prevent sustained innate immune signaling. Cell 155: 688-698.
39. Lee-Kirsch MA, Gong M, Chowdhury D, Senenko L, Engel K, Lee, Y-A, de Silva U, Bailey SL, Witte T, Vyse TJ, et al. 2007. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet 39: 1065-1067.
40. Li, X-D, Wu J, Gao D, Wang H, Sun L, Chen ZJ. 2013. Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science 341: 1390-1394.
41. Lim YW, Sanz LA, Xu X, Hartono SR, Chedin F. 2015. Genome-wide DNA hypomethylation and RNA: DNA hybrid accumulation in Aicardi-Goutières syndrome. Elife 2015;4: E08007.
42. Lindahl T, Barnes DE, Yang, Y-G, Robins P. 2009. Biochemical properties of mammalian TREX1 and its association with DNA replication and inherited inflammatory disease. Biochem Soc Trans 37: 535-538.
43. Liu Y, Jesus AA, Marrero B, Yang D, Ramsey SE, Montealegre Sanchez GA, Tenbrock K, Wittkowski H, Jones OY, Kuehn HS, et al. 2014. Activated STING in a vascular and pulmonary syndrome. N Engl J Med 371: 507-518.
44. Manils J, Casas E, Viña-Vilaseca A, López-Cano M, Díez-Villanueva A, Gómez D, Marruecos L, Ferran M, Benito C, Perrino FW, et al. 2016. The exonuclease Trex2 shapes psoriatic phenotype. J Invest Dermatol 136: 2345-2355.
45. Mazur DJ, Perrino FW. 1999. Identification and expression of the TREX1 and TREX2 cDNA sequences encoding mammalian 3'/5' exonucleases. J Biol Chem 274: 19655-19660.
46. Morita M, Stamp G, Robins P, Dulic A, Rosewell I, Hrivnak G, Daly G, Lindahl T, Barnes DE. 2004. Gene-targeted mice lacking the Trex1 (DNase III) 3'/5' DNA exonuclease develop inflammatory myocarditis. Mol Cell Biol 24: 6719-6727.
47. Nagata S, Kawane K. 2011. Autoinflammation by endogenous DNA. Adv Immunol 110: 139-161.
48. Orebaugh CD, Fye JM, Harvey S, Hollis T, Wilkinson JC, Perrino FW. 2013. The TREX1 C-terminal region controls cellular localization through ubiquitination. J Biol Chem 288: 28881-28892.
49. Osorio F, Reis e Sousa C. 2011. Myeloid C-type lectin receptors in pathogen recognition and host defense. Immunity 34: 651-664.
50. Parra D, Manils J, Castellana B, Viña-Vilaseca A, Morán-Salvador E, Vázquez-Villoldo N, Tarancón G, Borràs M, Sancho S, Benito C, et al. 2009. Increased susceptibility to skin carcinogenesis in TREX2 knockout mice. Cancer Res 69: 6676-6684.
51. Peschke K, Achleitner M, Frenzel K, Gerbaulet A, Ada SR, Zeller N, Lienenklaus S, Lesche M, Poulet C, Naumann R, et al. 2016. Loss of Trex1 in dendritic cells is sufficient to trigger systemic autoimmunity. J Immunol 197: 2157-2166.
52. Pokatayev V, Hasin N, Chon H, Cerritelli SM, Sakhuja K, Ward JM, Morris HD, Yan N, Crouch RJ. 2016. RNase H2 catalytic core Aicardi-Goutières syndrome-related mutant invokes cGAS-STING innate immune-sensing pathway in mice. J Exp Med 213: 329-336.
53. Robins P, Naven TJ, Pappin DJ, Lindahl T. 1999. A human DNA editing enzyme homologous to the Escherichia coli DnaQ/MutD protein. EMBO J 18: 3868-3875.
54. Schoggins JW, Macduff DA, Imanaka N, Gainey MD, Shrestha B, Eitson JL, Mar KB, Richardson RB, Ratushny AV, Litvak V, et al. 2014. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature 505: 691-695.
55. Sharma S, Campbell AM, Chan J, Schattgen SA, Orlowski GM, Nayar R, Huyler AH, Nündel K, Mohan C, Berg LJ, et al. 2015. Suppression of systemic autoimmunity by the innate immune adaptor STING. Proc Natl Acad Sci U S A 112: E710-E717.
56. Shrimal S, Ng BG, Losfeld, M-E, Gilmore R, Freeze HH. 2013. Mutations in STT3A and STT3B cause two congenital disorders of glycosylation. Hum Mol Genet 22: 4638-4645.
57. Stetson DB, Ko JS, Heidmann T, Medzhitov R. 2008. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134: 587-598.
58. Stetson DB, Medzhitov R. 2006. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 24: 93-103.
59. Sun L, Wu J, Du F, Chen X, Chen ZJ. 2013. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339: 786-791.
60. Vance RE. 2016. Cytosolic DNA sensing: The field narrows. Immunity 45: 227-228.
61. Vleugels W, Schollen E, Foulquier F, Matthijs G. 2009. Screening for OST deficiencies in unsolved CDG-I patients. Biochem Biophys Res Commun 390: 769-774.
62. Waßermann R, Gulen MF, Sala C, Perin SG, Lou Y, Rybniker J, Schmid-Burgk JL, Schmidt T, Hornung V, Cole ST, et al. 2015. Mycobacterium tuberculosis differentially activates cGAS-and inflammasome-dependent intracellular immune responses through ESX-1. Cell Host Microbe 17: 799-810.
63. Watson RO, Bell SL, Macduff DA, Kimmey JM, Diner EJ, Olivas J, Vance RE, Stallings CL, Virgin HW, Cox JS. 2015. The cytosolic sensor cGAS detects Mycobacterium tuberculosis DNA to induce type I interferons and activate autophagy. Cell Host Microbe 17: 811-819.
64. Wolf C, Rapp A, Berndt N, Staroske W, Schuster M, Dobrick-Mattheuer M, Kretschmer S, König N, Kurth T, Wieczorek D, et al. 2016. RPA and Rad51 constitute a cell intrinsic mechanism to protect the cytosol from self DNA. Nat Commun 7: 11752.
65. Woo, S-R, Corrales L, Gajewski TF. 2015. Innate immune recognition of cancer. Annu Rev Immunol 33: 445-474.
66. Woo, S-R, Fuertes MB, Corrales L, Spranger S, Furdyna MJ, Leung MYK, Duggan R, Wang Y, Barber GN, Fitzgerald KA, et al. 2014. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity 41: 830-842.
67. Wu J, Sun L, Chen X, Du F, Shi H, Chen C, Chen ZJ. 2013. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339: 826-830.
68. Wylie A, Jones AE, D'Brot A, Lu, W-J, Kurtz P, Moran JV, Rakheja D, Chen KS, Hammer RE, Comerford SA, et al. 2016. p53 genes function to restrain mobile elements. Genes Dev 30: 64-77.
69. Xia T, Konno H, Ahn J, Barber GN. 2015. Deregulation of STING signaling in colorectal carcinoma constrains DNA damage responses and correlates with tumorigenesis. Cell Rep 14: 282-297.
70. Yan N, Regalado-Magdos AD, Stiggelbout B, Lee-Kirsch MA, Lieberman J. 2010. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nat Immunol 11: 1005-1013.
71. Yang Y, Lindahl T, Barnes DE. 2007. Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease. Cell 131: 873-886.
72. Zhang X, Shi H, Wu J, Zhang X, Sun L, Chen C, Chen ZJ. 2013. Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING. Mol Cell 51: 226-235.